Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
Journal of Clinical Oncology 33(6) (2014)
Andrew Xiuxuan Zhu; Olivier Rosmorduc; Thomas R. Jeffry Evans; Paul J. Ross; Armando Santoro; Flair José Carrilho; Jordi Bruix; Shukui Qin; Paul Joseph Thuluvath; Josep Maria Llovet; Marie-Aude LeBerre; Markus Jensen; Gerold Meinhardt; Yoon‐Koo Kang
Prognostic and Predictive Biomarkers: Tools in Personalized Oncology
Molecular Diagnosis & Therapy 18(3) (2014)
Ewelina Nalejska; Ewa Mączyńska; Marzena Anna Lewandowska
Genetic alterations in hepatocellular carcinoma: An update
World Journal of Gastroenterology 22(41) (2016)
Zhao-Shan Niu; Xiao-Jun Niu; Wenhong Wang
Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
Cellular Signalling 26(5) (2014)
Dali Zhao; Bo Zhai; Changjun He; Gang Tan; Xian Li Jiang; Shangha Pan; Xuesong Dong; Zheng Wei; Lixin Ma; Haiquan Qiao; Hongchi Jiang; Xueying Sun
Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine
Genomics Proteomics & Bioinformatics 15(4) (2017)
Hala F. M. Kamel; Hiba Saeed A. Bagader Al-Amodi
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma
Oncology 94(6) (2018)
Melanie B. Thomas; Elizabeth S. Garrett-Mayer; Munazza Anis; Kate Anderton; Tricia Adrales Bentz; Andie Edwards; Alan Brisendine; Geoffrey R. Weiss; Abby B. Siegel; Johanna C. Bendell; Ari David Baron; Vinay Anant Duddalwar; Anthony B. El-Khoueiry
Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment Modulation of Breast Cancer
Journal of Personalized Medicine 11(2) (2021)
Ioana Bene; Sorin Marian Dudea; Anca Ileana Ciurea
Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems
Tumor Biology 36(1) (2014)
Jingjun Yan; Jiazhi Liao; Ju‐Sheng Lin; Xingxing He
Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
Molecules 27(17) (2022)
Monica A. Kamal; Yasmine M. Mandour; Mostafa K. Abd El‐Aziz; Ulrike Stein; Hend Mohamed El Tayebi
Ecto‐5′‐nucleotidase (CD73) is a potential target of hepatocellular carcinoma
Journal of Cellular Physiology 234(7) (2018)
Shalaimaiti Shali; Jiangang Yu; Xin Zhang; Xue Wang; Youping Jin; Minsheng Su; Xiaohong Liao; Jerry Yu; Xiuling Zhi; Ping Zhou
EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma
Scientific Reports 6(1) (2016)
Chuangye Han; Xiwen Liao; Wei Qin; Long Yu; Xiaoguang Liu; Gang Chen; Zhengtao Liu; Sicong Lu; Zhiwei Chen; Hao Su; Guangzhi Zhu; Zili Lu; Zhiming Liu; Xue Ying Qin; Ying Gui; Zengnan Mo; Le‐Qun Li; Tao Peng
miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis
OncoTargets and Therapy Volume 14 (2021)
Yaqian Niu; Fang Liu; Xiuyue Wang; Yu‐Ling Chang; Yanmei Song; Huiyuan Chu; Shisan Bao; Che Chen
Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study
OncoTargets and Therapy Volume 10 (2017)
Yixuan Zhao; Shuang Liu; Yanbing Hu; Yan-Yan Ge; Dongmei Lv
Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma
Oncology Reports 31(6) (2014)
LI-LI HAN; Haocheng Nan; Tao Tian; Hui Guo; Tinghua Hu; Wenjuan Wang; Jiequn Ma; Lili Jiang; Qianqian Guo; Chengcheng Yang; Xiaomin Kang; Ying Liu; Yuan Gao; Qilun Liu; Kejun Nan
Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome
Oncotarget 10(20) (2019)
Ge Yan; Mohamed E.M. Saeed; Sebastian Foersch; José Schneider; Wilfried Roth; Thomas Efferth
2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop
Pharmacological Research 169 (2021)
Shufang Zheng; Jiaping Ni; Ying Li; Ming‐Ying Lu; Yuchen Yao; Haixin Guo; Meng Jiao; Tianle Jin; Haoying Zhang; Ansheng Yuan; Zhuo Wang; Yong Yang; Zhen Chen; Hongxi Wu; Weiwei Hu
Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy
Seminars in Radiation Oncology 28(4) (2018)
Florence K. Keane; Theodore Sunki Hong; Andrew Xiuxuan Zhu
Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF/mToR Signaling
Evidence-based Complementary and Alternative Medicine 2022 (2022)
Shuai Lin; Qianwen Sheng; Xiaobin Ma; Shanli Li; Peng Xu; Cong Dai; Meng Wang; Huafeng Kang; Zhijun Dai
Genomic biomarkers to guide precision radiotherapy in prostate cancer
The Prostate 82(S1) (2022)
Philip Anthony Sutera; Matthew Pierre Deek; Kim Van der Eecken; Alexander William Wyatt; Amar Upadhyaya Kishan; Jason K. Molitoris; Matthew Jeffrey Ferris; M. Minhaj Siddiqui; Zaker Hamid Rana; Mark Vikas Mishra; Young Kwok; Elai Davicioni; Daniel Eidelberg Spratt; Piet Ost; Felix Yi-Chung Feng; Phuoc Tho Tran
Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer
Cancer Letters 411 (2017)
Ling Jin; Mei-Hua Jin; Ah‐Rong Nam; Ji-Eun Park; Ju‐Hee Bang; Do‐Youn Oh; Yung‐Jue Bang
Crosstalk between EGFR and p53 in Hepatocellular Carcinoma
Asian Pacific Journal of Cancer Prevention 15(19) (2014)
Andreea Cioca; Anca Maria Cîmpean; Raluca Amalia Ceauşu; Ana-Maria Fit; Teodor Zaharie; Nadim Al Hajjar; Vlad Radu Puia; Marius Raica
Roles of XRCC1 / XPD / ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization
Genetic Testing and Molecular Biomarkers 20(4) (2016)
Xu-Cai Wang; Fan Wang; Qingqing Quan
Different Faces of Hepatocellular Carcinoma as a Health Threat in 21st Century
Hepatitis Monthly 13(2) (2013)
Behzad Yeganeh; Mohammad Mostakhdem Hashemi; Fredrick J. de Serres; Marek Łoś; Saeid Ghavami
Progress in research on association between cell signal transduction pathways and hepatocellular carcinoma
World Chinese Journal of Digestology 27(21) (2019)
Chun Chen; Zhe Yang; Zan-Song Huang
Expression and Clinical Significance of ERCC1 and XPF in Human Hepatocellular Carcinoma
OncoTargets and Therapy Volume 13 (2020)
Xiaoli Liao; Yongqiang Li; Li hualan; Wenfeng Huang; Hongxue Wang; Weimin Xie
Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
Gastrointestinal Cancer Targets and Therapy 5 (2015)
Autumn J. McRee; Adam B. Sendor; Kathryn E. Hacker; Shufen Chen; Oishee Sen; Derek Yung-ho Chiang; Anna C. Snavely; Arlin B. Rogers; Stephanie A. Montgomery; W. Kimryn Rathmell; Armando L. Corona
Growth Regulation in Hepatobiliary Cancer: Regulators of the Cell Division Cycle
Springer eBooks (2016)
Arthur Zimmermann
Is the Expression of p53, c-erb-B2 and Ki-67 Influence the Prognosis of the Non-muscle Invasive Urothelial Bladder Cancer?
Journal of Urologic Oncology 14(2) (2016)
Seok Hyun Kang; Hyun Jin Jung; Eun Kyoung Yang; Jae Shin Park; Hoon Kyu Oh; Duk Yoon Kim
Growth Regulation in Hepatobiliary Cancer: Regulators of the Cell Division Cycle
Springer eBooks (2016)
Arthur Zimmermann